Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?

Motley Fool

Published

Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.

Full Article